May 2014 FDA Recall Dextroamphetamine Sulfate by Teva Pharmaceuticals Usa
D-1408-2014 - Failed Impurities/Degradation Specifications

This Class II drug recall was voluntarily initiated by Teva Pharmaceuticals Usa on May 1, 2014 for the product Dextroamphetamine Sulfate. The FDA reported the reason for recall as failed impurities/degradation specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1408-2014

Reason for Recall
Failed Impurities/Degradation Specifications: this product is being recalled due to an out of specification test result for impurities during stability testing.
Initiated
05-01-2014
Reported
07-02-2014
Quantity
9,882 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Teva Pharmaceuticals USA
Nationwide and Puerto Rico
Dextroamphetamine Sulfate Tablets, USP, 10 mg, 100-count bottles, Rx only, Barr Laboratories, Inc., Pomona, NY 10970, NDC 0555-0953-02.

Batch or Lot Expiration Information

Lot# 34013122A, Exp 11/15